Dear Investors,
If you've made it here, you're interested in partnering with us or buying us out. MD Medical Research is a small company measured by head count, but it has big margins. We're on track to generate about $1.5m in 2023. As our site continues to evolve its operations to constantly become more efficient, it's also our expectation to double revenue any given year. Our Director of Research & Business Development focuses on growing revenues and eliminating unnecessary costs; revenue has tripled over the past 6 years. Many clinical research sites don't survive; however, Sponsors frequently entrust MD Medical Research to collect and provide accurate data to help bring meaningful investigational products to the market. Our staff are excited about the work that we do, because we believe we are developing advancements in medicine and also in the way sites should operate. We can become a consulting company. We believe that we are probably the most technologically advanced clinical research site worldwide, and our goal is to operate hyper-efficiently, then expand and continue to improve. With an investor partnership, funding can help to accelerate expansion and growth. With an investor buyout, investors can fully own MD Medical Research, a fast-growing yet well-established clinical research site, including control of its repository of ongoing and future trials, vendor relationships, and access to a database of about 30,000 patients. For additional information, please contact Spencer Ong at [email protected].
Happy hunting,
MD Medical Research
If you've made it here, you're interested in partnering with us or buying us out. MD Medical Research is a small company measured by head count, but it has big margins. We're on track to generate about $1.5m in 2023. As our site continues to evolve its operations to constantly become more efficient, it's also our expectation to double revenue any given year. Our Director of Research & Business Development focuses on growing revenues and eliminating unnecessary costs; revenue has tripled over the past 6 years. Many clinical research sites don't survive; however, Sponsors frequently entrust MD Medical Research to collect and provide accurate data to help bring meaningful investigational products to the market. Our staff are excited about the work that we do, because we believe we are developing advancements in medicine and also in the way sites should operate. We can become a consulting company. We believe that we are probably the most technologically advanced clinical research site worldwide, and our goal is to operate hyper-efficiently, then expand and continue to improve. With an investor partnership, funding can help to accelerate expansion and growth. With an investor buyout, investors can fully own MD Medical Research, a fast-growing yet well-established clinical research site, including control of its repository of ongoing and future trials, vendor relationships, and access to a database of about 30,000 patients. For additional information, please contact Spencer Ong at [email protected].
Happy hunting,
MD Medical Research